Understanding how certain immune cells control allergic responses in asthma
Lung resident Treg suppression of Th2 resident memory T cells in allergicasthma
This study is looking at how certain immune cells called Tregs help control allergic reactions in asthma, and it aims to find new ways to treat asthma by understanding how these cells keep inflammation in check when you're exposed to allergens.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11003793 on NIH RePORTER |
What this research studies
This research investigates the role of FoxP3+ regulatory T cells (Tregs) in managing allergic reactions to common allergens in asthma. It focuses on how these Tregs suppress the activity of T helper type 2 (Th2) memory T cells that become activated during allergen exposure. By using advanced techniques such as gene editing and single-cell RNA sequencing, the study aims to uncover the mechanisms that allow Tregs to limit inflammation in the lungs. This could lead to new therapies for asthma and other allergic diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with allergic asthma, particularly those who experience severe allergic reactions to airborne allergens.
Not a fit: Patients with non-allergic asthma or those whose asthma is not triggered by allergens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that better control asthma symptoms and improve the quality of life for patients with allergic asthma.
How similar studies have performed: Previous research has shown promising results in understanding the role of Tregs in allergic responses, suggesting that this approach could yield valuable insights.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Nelson, Ryan William — University of Minnesota
- Study coordinator: Nelson, Ryan William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.